GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Short-term investments

Frontage Holdings (HKSE:01521) Short-term investments


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Short-term investments?

Short-term investments only applies to insurance companies.


Frontage Holdings Business Description

Traded in Other Exchanges
N/A
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical, and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include drug discovery, drug development, pharmaceutical product development, and laboratory testing in the USA and Canada; and the PRC segment includes the same services provided in the People's Republic of China. The company generates a majority of its revenue from USA followed by the PRC and the rest of the world.
Executives
Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si 2101 Beneficial owner
Li Song 2101 Beneficial owner
Kabouter Management Llc 2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.
Hongkong Tigermed Co., Limited